About
Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exports its products. Norris Medicines Limited was incorporated in 1990 and is based in Ankleshwar, India.
Key Metrics
as of Sep 2026Market Cap14 Cr
P/E—
Div Yield0.00 %
Book Value₹-15.10
52w High₹19.60
52w Low₹12.00
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.92 | 1.41 | 3.27 | 2.00 | 1.46 | 2.72 | 1.11 | 1.27 | 0.72 | 1.49 | 0.65 | 2.56 | 0.95 |
| Expenses | 1.20 | 1.11 | 2.32 | 2.49 | 1.56 | 2.65 | 1.14 | 1.42 | 0.88 | 1.01 | 0.69 | 2.80 | 1.33 |
| Operating Profit | -0.28 | 0.30 | 0.95 | -0.49 | -0.10 | 0.07 | -0.03 | -0.15 | -0.16 | 0.48 | -0.04 | -0.24 | -0.38 |
| OPM % | -30.43 | 21.28 | 29.05 | -24.50 | -6.85 | 2.57 | -2.70 | -11.81 | -22.22 | 32.21 | -6.15 | -9.38 | -40.00 |
| Other Income | 0.00 | 0.02 | 0.00 | 0.00 | 0.02 | 0.05 | 0.00 | 0.00 | 0.01 | 0.03 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.11 | 0.12 | 0.12 | 0.12 | 0.12 | 0.14 | 0.13 | 0.13 | 0.13 | 0.14 | 0.14 | 0.14 | 0.14 |
| Interest | 0.00 | 0.15 | 0.13 | 0.11 | 0.11 | 0.15 | 0.12 | 0.08 | 0.08 | 0.11 | 0.09 | 0.09 | 0.09 |
| Profit before tax | -0.39 | 0.05 | 0.70 | -0.72 | -0.31 | -0.17 | -0.28 | -0.36 | -0.36 | 0.26 | -0.27 | -0.47 | -0.61 |
| Tax % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 35.29 | 0.00 | 0.00 | 0.00 | 34.62 | 0.00 | 0.00 | 0.00 |
| Net Profit | -0.40 | 0.05 | 0.70 | -0.72 | -0.31 | -0.23 | -0.28 | -0.36 | -0.37 | 0.17 | -0.27 | -0.48 | -0.61 |
| EPS in Rs | -0.40 | 0.05 | 0.70 | -0.72 | -0.31 | -0.23 | -0.28 | -0.36 | -0.37 | 0.17 | -0.27 | -0.48 | -0.61 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.13 | 5.82 | 5.64 | 8.36 | 9.44 | 12.25 | 7.84 | 16.26 | 13.57 | 20.46 | 18.86 | 18.68 |
| Expenses | 7.47 | 6.08 | 5.81 | 7.43 | 9.52 | 14.00 | 10.00 | 16.87 | 15.49 | 20.46 | 18.03 | 16.97 |
| Operating Profit | 0.66 | -0.26 | -0.17 | 0.93 | -0.08 | -1.75 | -2.16 | -0.61 | -1.92 | 0.00 | 0.83 | 1.71 |
| OPM % | 8.12 | -4.47 | -3.01 | 11.12 | -0.85 | -14.29 | -27.55 | -3.75 | -14.15 | 0.00 | 4.40 | 9.15 |
| Other Income | 0.05 | 0.06 | 0.01 | 0.01 | 0.03 | 0.05 | 0.09 | 0.04 | 0.14 | 0.06 | 0.30 | 0.15 |
| Interest | 0.50 | 0.44 | 0.37 | 1.50 | 1.48 | 1.63 | 0.88 | 0.73 | 0.70 | 0.60 | 0.67 | 0.54 |
| Depreciation | 0.49 | 0.54 | 0.57 | 0.63 | 0.66 | 0.67 | 0.73 | 0.71 | 0.71 | 0.65 | 0.60 | 1.31 |
| Profit before tax | -0.28 | -1.18 | -1.10 | -1.19 | -2.19 | -4.00 | -3.68 | -2.01 | -3.19 | -1.19 | -0.14 | 0.01 |
| Tax % | 0.00 | 5.08 | 8.18 | 47.06 | 49.32 | 24.25 | -22.83 | -16.42 | -21.00 | -35.29 | -128.57 | 10,500.00 |
| Net Profit | -0.28 | -1.24 | -1.19 | -1.75 | -3.26 | -4.96 | -2.84 | -1.68 | -2.51 | -0.77 | 0.04 | -1.04 |
| EPS in Rs | -0.28 | -1.24 | -1.19 | -1.75 | -3.26 | -4.96 | -2.84 | -1.68 | -2.51 | -0.77 | 0.04 | -1.04 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 |
| Reserves | -25.07 | -24.79 | -23.56 | -22.37 | -20.62 | -17.36 | -12.39 | -9.55 | -7.88 | -5.36 | -4.60 | -4.63 |
| Borrowings | 21.53 | 21.58 | 21.52 | 21.40 | 21.08 | 15.52 | 17.92 | 11.24 | 7.71 | 7.57 | 7.51 | 8.16 |
| Other Liabilities | 6.50 | 7.09 | 6.29 | 4.72 | 3.80 | 11.69 | 5.10 | 8.76 | 10.92 | 9.90 | 5.06 | 4.69 |
| Total Liabilities | 12.89 | 13.81 | 14.18 | 13.68 | 14.19 | 19.78 | 20.56 | 20.38 | 20.68 | 22.04 | 17.90 | 18.15 |
| Fixed Assets | 4.79 | 5.27 | 5.79 | 6.47 | 7.07 | 7.67 | 8.25 | 8.90 | 9.32 | 9.97 | 8.34 | 8.61 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Other Assets | 8.09 | 8.53 | 8.38 | 7.20 | 7.11 | 12.10 | 12.30 | 11.47 | 11.35 | 12.06 | 9.55 | 9.53 |
| Total Assets | 12.89 | 13.81 | 14.18 | 13.68 | 14.19 | 19.78 | 20.56 | 20.38 | 20.68 | 22.04 | 17.90 | 18.15 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.58 | 0.51 | 0.17 | 1.20 | -1.01 | 1.11 | -2.88 | -1.92 | 0.80 | -0.96 | 1.35 | -1.43 |
| Cash from Investing Activity | -0.08 | 0.00 | 0.05 | -0.02 | -0.09 | -0.06 | 0.00 | -0.29 | -0.08 | -2.05 | -0.34 | -0.88 |
| Cash from Financing Activity | -0.52 | -0.50 | -0.20 | -1.18 | 1.10 | -1.09 | 2.86 | 2.18 | -0.66 | 3.16 | -1.32 | 0.10 |
| Net Cash Flow | -0.02 | 0.00 | 0.02 | 0.00 | 0.00 | -0.04 | -0.02 | -0.02 | 0.06 | 0.15 | -0.31 | -2.21 |
| Free Cash Flow | 0.57 | 0.49 | 0.26 | 1.17 | -1.07 | 1.02 | -2.96 | -2.21 | 0.74 | -3.24 | 1.03 | -2.30 |
| CFO/OP % | 88.00 | -196.00 | -100.00 | 129.00 | 1,262.00 | -63.00 | 133.00 | 315.00 | -42.00 | — | 163.00 | -84.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52.53 | 88.43 | 68.60 | 48.03 | 42.15 | 53.33 | 128.49 | 67.57 | 66.44 | 84.20 | 53.61 | 73.66 |
| Inventory Days | 337.84 | 436.94 | 594.15 | 347.62 | 157.45 | 212.99 | 323.82 | 134.81 | 238.53 | 129.50 | 134.23 | 100.05 |
| Days Payable | 222.40 | 271.90 | 244.25 | 149.91 | 86.53 | 218.83 | 233.37 | 139.83 | 252.40 | 125.29 | 99.30 | 111.66 |
| Cash Conversion Cycle | 167.97 | 253.47 | 418.51 | 245.73 | 113.06 | 47.49 | 218.94 | 62.55 | 52.56 | 88.41 | 88.54 | 62.06 |
| Working Capital Days | -167.91 | -241.45 | -202.56 | -122.25 | -97.82 | -103.69 | -30.73 | -32.55 | -91.18 | -16.06 | 34.84 | 27.75 |
| ROCE % | 3.36 | -10.13 | -8.43 | 3.20 | -7.68 | -20.13 | -20.68 | -11.97 | -22.92 | -4.08 | 4.03 | 4.02 |
Corporate Actions
2 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Other | 22 Aug 2013 | 23 Aug 2013 | — | — | Reduction of Capital |
| Other | 22 Aug 2013 | 23 Aug 2013 | — | — | Consolidation of Shares |